<DOC>
	<DOCNO>NCT00801658</DOCNO>
	<brief_summary>Examination follow-up efficacy safety SLT patient unsufficient IOP control despite maximum tolerated topical therapy . In addition , examine whether medical treatment reduce SLT procedure whether filter surgery - remain option - may postpone .</brief_summary>
	<brief_title>Efficacy SLT Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy ( Eye Drops )</brief_title>
	<detailed_description>SLT ( Selective Laser Trabeculoplasty ) use Nd : YAG-Lasers ( wavelength 532nm , Q-switched , frequency-doubled ) . Thanks low laser energy use short duration treatment , pigment cell trabecular meshwork target selectively treat . Neighboring , non-pigmented cell tissue spar collateral thermic damage , architecture trabecular meshwork remain intact . The SLT procedure use less 1 % energy ALT procedure extremely low pulsation duration . Several study confirm effective IOD reduction SLT rate procedure relatively safe effective therapy glaucoma . Also repeat use SLT procedure consider meaningful . Meanwhile SLT procedure use primary supplementary treatment glaucoma study confirm SLT procedure effective administration Latanoprost reduce IOD newly-diagnosed glaucoma .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Inclusion criterion : Patients primary open angle glaucoma ( include normal tension glaucoma ) pseudoexfoliation glaucoma pigment dispersion glaucoma Exclusion criterion : previous intraocular surgery close angle glaucoma pediatric glaucoma inflammatory uveitic glaucoma unclear view trabecular meshwork</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>SLT</keyword>
	<keyword>Laser treatment</keyword>
	<keyword>IOP</keyword>
	<keyword>glaucoma treat eye drop IOP control</keyword>
</DOC>